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CHAPTER 15 
Extrapolation of Animal Research Data to Humans: 
An Analysis of the Evidence 
Rebecca Ram 
Clinical Data Management and Scientific Research Consultant 
rebeccanram@aolcom 
The ethical arguments against animal experimentation remain ever-strong. 
In addition, the scientific case against the use of animals in research grows 
more compelling, with exponential progress in the development of alterna­
tive methods and new research technologies. The Dutch authorities recently 
announced an ambitious, but welcome, proposal to phase out "the use of labo­
ratory animals in regulatory safety testing of chemicals, food ingredients, pes­
ticides and (veterinary) medicines" by 2025, as well as "the use of laboratory 
animals for the release of biological products, such as vaccines" (Netherlands 
National Committee for the protection of animals used for scientific pur­
poses, NC ad, 2016 1 p. 3). National government departments ( e.g., the United 
Kingdom, UK, Home Office) have stated that alternatives to animals are now 
considered necessary for scientific as much as ethical reasons, also conceding 
that pressure exists within the research community to use animals in order 
to get published. Furthermore, only 20% of animal tests across the European 
Union (Eu) each year are conducted to meet regulatory requirements, with the 
vast majority carried out as basic research (including basic medical research) 
or breeding of genetically modified (GM) animals at academic institutions 
(European Commission, 2013b ). 
Despite the strength of both scientific and moral arguments, animal re­
search continues to increase worldwide, especially given the rising trend in use 
of GM animals. A Catch 22 situation also exists, with regulators largely refusing 
to break with tradition and continuing to accept only animal data, even 
when robust human-based data exists. Additionally, when new animal-free, 
human-relevant methods are developed, regulators often insist that research 
still be performed on animals; this is considered to be one of the major barri­
ers to achieving change and, in turn, results in an industry reluctant to invest 
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in non-animal research, if its results are unlikely to be accepted (Schiffelers 
et al. , 2012 ). 
Whilst public engagement, via campaigns to highlight animal suffering, 
remains vital, a renewed focus on scientific, political, and financial interests 
is needed. This focus is needed to emphasize the fundamental message that 
animal research simply does not deliver what is needed, in order to influence 
those who regulate, finance, or approve animal experiments and have a mean­
ingful impact on their ongoing reduction but primarily, their replacement. Sci­
entific evidence is needed, on an ongoing basis, of the inadequacy of animal 
experiments in predicting human outcomes, combined with a focus on the 
modern, non-animal techniques that have the potential to replace them, to 
drive an ongoing recognition of the need for genuine, significant investment 
in human-relevant research. Additionally, not all animal tests need replacing, 
many can simply end; so providing appropriate evidence of these types of tests 
is also essential. 
In striving to achieve a paradigm shift to end animal experimentation, for 
scientific as much as ethical reasons, an evidence-based approach is required. 
There remains a vital need for a combination of drivers in innovative, animal­
free scientific research, training, and education, as well as continued lobbying 
and campaigning to key stakeholders (i.e. , scientists, regulators, and political 
audiences). 
Animal experimentation falls into two broad categories: basic research (in­
cluding basic medical research) and a relatively smaller category, toxicity ( or 
safety) testing of new substances, which includes chemicals for use in personal 
care, household products, industrial substances, foodstuffs, or pharmaceuticals 
(the latter are also tested for efficacy). There is overlap, to some extent, in these 
categories, with some animal procedures categorized as "fundamental toxicol­
ogy': for example. A two-fold strategy is suggested to end the use of animals 
in all experimental research. The first should focus on how a large number of 
procedures performed, both in basic research and product-safety testing, can 
simply end today; in other words, they do not need non-animal replacements. 
The second should focus on procedures that are considered to require replace­
ment. This could be through intelligent and strategic combinations of existing 
non-animal tests (integrated testing strategies) and/or further development of 
new human-relevant models. Examples of these and their success in replacing 
animals to date are discussed later in this chapter. 
A popular argument in support of continuing animal research is that they 
have been used for decades in the research and development of new medi­
cines. The fact that millions of animals have been used over years, often in 
the same repeated experiments, is not in dispute. However, their continued 
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use does not prove necessity. It is also relevant to note that from early on in a 
scientific career, one is discouraged from saying that experiments "didn't work" 
but instead, to conclude how further research or new approaches must be tried 
next, in light of unsuccessful or unexpected results. The use of animals has 
been grandfathered through, due to convention, anecdotal evidence or belief, 
rather than robust scientific validity. "We must use a living system" . . .  but it is 
the wrong living system and no matter how many animals are used, they will 
never provide an appropriate model for humans. This needs to change, par­
ticularly when considering the growing industry of breeding and supplying 
millions of GM animals worldwide each year, in repeated attempts to mimic 
the human condition. 
The vast majority of animals are used either for basic research or breed­
ing of GM strains. This is clear when reviewing recent official statistics for the 
three highest animal-using countries in the EU; the UK, Germany, and France. 
For example, more than 3.9 million procedures on animals (mice, rats, rabbits, 
guinea pigs, dogs, horses, cats, non-human primates, pigs, sheep, cattle, birds, 
xenopus, and fish, among other species) were carried out in the UK in 2016. Of 
these, 729,390 were genetically modified, including more than 149,000 animals 
deliberately bred to suffer a harmful phenotype ( a deliberately induced condi­
tion, such as cancer, failed immune system, or organ failure to try to simulate 
disease in humans). There were also increases in the number of experiments 
across several species, and a significant number of experiments for ingredients 
in household products (1700 procedures), to meet industrial chemicals legisla­
tion requirements, despite a policy on testing for such purposes (Home Office, 
2017 ). In fact, of the total 3.9 million procedures conducted in the UK in 2016, 
only 13% were carried out for regulatory purposes. Germany bred 1. 2 million 
GM animals in 2015 (with similar numbers of harmful phenotype animals to 
the UK), representing 42% of the 2.8 million animals used annually (Federal 
Ministry of Food and Agriculture, 2016). Figures reported for France in 2014 
show that 1.8 million animals were used, however the proportion of GM ani­
mals was not reported (Ministry of Higher Education & Research, 2016). 
Several thousand diseases affect humans. Of these, only 500 currently have 
FDA-approved treatments available (National Center for Advancing Transla­
tional Sciences, 2017 ). In every discipline of disease research, animals are used 
on an ongoing basis, yet it is continually reported that mechanisms of human 
conditions investigated in such animals are still not understood. This is be­
cause basic research in animals is a demand-driven and self-perpetuating sys­
tem, with much research being proposed and licensed on the basis of being 
repetitively performed on animals ( often termed as "well established" or "well 
documented" models). Such research is neither legally required, nor does it 
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have to be relevant or applicable to human disease to be licensed. Another 
key barrier to replacing animals, even when scientifically valid alternatives are 
available, is awareness and acceptance of their use, both by researchers and 
regulators (Ramirez et al. , 2015). 
The first part of this chapter provides an analysis of extrapolation of ani­
mal studies to humans, by sampling systematic reviews carried out to assess 
evidence of clinical translation and incorporating a review of literature on 
animal toxicity studies for some well-known, established case study drugs ( e.g. ,  
paracetamol, aspirin, penicillin) and animal versus human findings. The sec­
ond part addresses drivers for change and the development of animal-free ( or 
rather, human-relevant) research methods, as well as some examples of pro­
cedures that do not need replacing as they can simply stop, when considering 
that they can logically be avoided or rejected on the basis of a correctly per­
formed ( and legally required) harm-benefit assessment. The chapter aims to 
provide an overview of the above topics and suggestions for the way forward as 
part of a new paradigm for a global, animal-research free future. 
1 Part 1: Analysis of Abstracts from Systematic Reviews of Animal 
Studies 
To carry out an analysis of systematic reviews on animal experiments, a re­
view of a sample of available literature was performed. The intention of this 
analysis was to provide a generally qualitative review of the literature. To do so, 
two separate sources were used. First, a search in PubMed (National Centre for 
Biotechnology Information, 2016) was made using the keyword search of "sys­
tematic review animal studies." This resulted in a total of 163,585 publications. 
PubMed allows search by Article Type and selecting this as "systematic review" 
further filtered results to 8, 291 listings, also sorted by relevance. Second, the 
Google Scholar database, using the same search terms, "systematic review ani­
mal studies," for consistency, yielded 2,530,000 results (Google Scholar, 2016). 
Dates of publications ranged from 1999-present. Generally, PubMed provided 
more recent listings compared to Google Scholar, which resulted in older pub­
lications; but this was useful to provide a greater scope for review over the past 
two decades as well as avoid duplication. 
To account for time constraints, while still providing a reasonable sample 
size, the first 50 abstract listings within each source were reviewed, giving a 
sample total of 100 ( see Table 15. 1 ). If a publication appeared within both sourc­
es, this was also accounted for, although duplicates were relatively few. Where 
publications were found to be not relevant, further listings were reviewed to 
compensate for this and to maintain a total of 100. 
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costeroids in Animals: A Systematic Review. Americanjoumal of 
Obstetrics & Gynecology, 186(4), pp. 843-849. 
Angst, M. and Clark, J. ( 2006). Opioid-induced Hyperalgesia: 
A Qualitative Systematic Review. Anesthesiology, 104(3), 
pp. 570-587. 
Antonie, A., Sena, E., Lees, J., Wills, T., Skeers, P., Batchelor, P., 
Macleod, M. and Howells, D. (2013). Stem Cell Transplanta­
tion in Traumatic Spinal Cord Injury: A Systematic Review and 
Meta-analysis of Animal Studies. Public Library of Science Biology, 
11(12), p. e1001738. 
Bellomo, R., Ronco, C., Kellum,J., Mehta, R., Palevsky, P. and 
the ADQI Workgroup. (2004). Acute Renal Failure-Definition, 
Outcome Measures, Animal Models, Fluid Therapy and Informa-
tion Technology Needs: The Second International Consensus 
Conference of the Acute Dialysis Quality Initiative (ADQI) Group. 







55 Bjordal, J., Johnson, M., Iversen, V., Aimbire, F. and Lopes-Martins, Google 
56 
57 
R. ( 2006 ). Low-level Laser Therapy in Acute Pain: A Systematic Scholar 
Review of Possible Mechanisms of Action and Clinical Effects in 
Randomized Placebo-controlled Trials. Photomedicine and Laser 
Surgery, 24(2), pp. 158-168. 
Cave, G. and Harvey, M. ( 2009 ). Intravenous lipid Emulsion As Google 
Antidote Beyond Local Anesthetic Toxicity, A Systematic Review. Scholar 
Academic Emergency Medicine, 16(9), pp. 815-824. 
Corpet, D. and Pierre, F. ( 2003 ). Point: From Animal Models to 
Prevention of Colon Cancer. Systematic Review of Chemopre­
vention in Min Mice and Choice of the Model System. Cancer 
Epidemiology, Biomarkers & Prevention, 12(5 ), pp. 391-400. 
Google 
Scholar 
58 Corpet, D. and Pierre, F. (2005). How Good Are Rodent Models of Google 
59 
Carcinogenesis in Predicting Efficacy in Humans? A Systematic Scholar 
Review and Meta-analysis of Colon Chemoprevention in Rats, 
Mice and Men. Europeanjoumal of Cancer, 41(13), 
pp. 1911-1922. 
Dangour, A., Lock, K., Hayter, A., Aikenhead, A., Allen, E., Uauy, 
R. ( 2010 ). Nutrition-related Health Effects of Organic Foods: A 
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TABLE 15.1 Publications included in abstract review (n=100) (cont.) 
Number Reference Source 
60 Falagas, M., Kastoris, A., Karageorgopoulos, D. and Rafailidis, Google 
P. ( 2009 ). Fosfomycin for the Treatment of Infections Caused by Scholar 
Multidrug-resistant Non-fermenting Gram-negative Bacilli: A Sys-
tematic Review of Microbiological, Animal and Clinical Studies. 
Internationaljournal of Antimicrobial Agents, 34( 2 ), pp. 111 -120. 
61 Fehlings, M. and Perrin, R. ( 2006). The Timing of Surgical Inter- Google 
vention in the Treatment of Spinal Cord Injury: A Systematic Scholar 
Review of Recent Clinical Evidence. Spine, 15;31( 11 ), pp. S28-36. 
62 Giannobile, W. and Somerman, M. ( 2003 ). Growth and Amelo- Google 
genin-like Factors in Periodontal Wound Healing, A Systematic Scholar 
Review. Annals of Periodontology, 8( 1 ), pp. 193-204. 
63 Gibson, C., Gray, L., Bath, P. and Murphy, S. (2008). Progesterone Google 
for the Treatment of Experimental Brain Injury; A Systematic 
Review. Brain, 131 (2), pp. 318-328. 
Scholar 
64 Gibson, C. and Murphy, S. ( 2010  ). Benefits of His tone Deacetylase Google 
Inhibitors for Acute Brain Injury: A Systematic Review of Animal Scholar 
Studies.Journal ofNeurochemistry, n5(4), pp. 806-813. 
65 Hasani-Ranjbar, S., Nayebi, N., Larijani, B. and Abdollahi, M. Google 
( 2009 ). A Systematic Review of the Efficacy and Safety of Herbal Scholar 
Medicines Used in the Treatment of Obesity. Worldjoumal of 
Gastroenterology, 15(25), pp. 3073-3085. 
66 Henderson, V., Kimmelman, J., Fergusson, D., Grimshaw, J. and Google 
Hackam, D. (2013). Threats to Validity in the Design and Conduct Scholar 
of Preclinical Efficacy Studies: A Systematic Review of Guidelines 
for In Vivo Animal Experiments. Public Library of Science Medi-
cine, 10(7), p. e1001489. 
Hooijmans, C., Leenaars, M. and Ritskes-Hoiting, M. (2010). 
A Gold Standard Publication Checklist to Improve the Quality 
of Animal Studies, to Fully Integrate the Three Rs, and to Make 
Systematic Reviews More Feasible. Alternatives to Laboratory 
Animals, 38(2), pp. 167-182. 
Google 
Scholar 
68 Hom, J., de Haan, R., Vermeulen, M., Luiten, P. and Limburg, M. Google 
( 2001 ). Nimodipine in Animal Model Experiments of Focal Cere- Scholar 
bral Ischemia: A Systematic Review. Stroke, 32( 1 o ), 
pp. 2433-2438. 
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69 Houben, M., van de Beek, D., Hensen, E., de Craen, A., Rauws, E. Google 
and Tytgat, G. ( 1999 ). A Systematic Review of Helicobacter Pylori Scholar 
70 
71 
Eradication Therapy-The Impact of Antimicrobial Resistance 
on Eradication Rates. Alimentary Pharmacology & Therapeutics, 
13(8), pp. 1047-1055. 
Jamaty, C., Bailey, B., Larocque, A., Notebaert, E., Sanogo, K., 
Chauny,J. (2010). Lipid Emulsions in the Treatment of Acute 
Poisoning: A Systematic Review of Human and Animal Studies. 
Clinical toxicology (Philadelphia, PA ), 48( 1 ), pp. 1-27. 
Javed, F. and Romanos, G. (2009). Impact of Diabetes Mellitus 
and Glycemic Control on the Osseointegration of Dental Im­
plants: A Systematic Literature Review.Journal of Periodontology, 





72 Junker, R., Dimakis, A., Thoneick M. and Jansen,]. (2009). Effects Google 
of Implant Surface Coatings and Composition on Bone Integra- Scholar 
tion: A Systematic Review. Clinical Oral Implants Research, 20 
(s4), pp. 185-206. 
73 Kilkenny, C., Browne, W.J, Cuthill, I.C., Emerson, M., Altman, D.G. Google 
74 
( 2010 ). Improving Bioscience Research Reporting: The ARRIVE Scholar 
Guidelines for Reporting Animal Research.journal of Pharmacol-
ogy and Pharmacotherapeutics, 1 ( 2 ), pp. 94-99. 
Kwon, B., Okon, E., Hillyer,J., Mann, C., Baptiste, D., Weaver, L., 
Fehlings, M. and Tetzlaff, W. ( 2011 ). A Systematic Review of 
Non-invasive Pharmacologic Neuroprotective Treatments for 




75 Lamontagne, F., Briel, M., Duffett, M., Fox-Robichaud, A., Cook, Google 
D., Guyatt, G., Lesur, 0. and Meade, M. (2010 ). Systematic Review Scholar 
of Reviews Including Animal Studies Addressing Therapeutic 
Interventions for Sepsis. Critical Care Medicine, 38( 12 ), 
pp. 2401-2408. 
76 Langenberg, C., Bagshaw, S., May, C. and Bellomo, R. (2008). Google 
The Histopathology of Septic Acute Kidney Injury: A Systematic Scholar 
Review. Critical Care, 12(2 ), R38. 
77 Lerchbaum, E. and Obermayer-Pietsch, B. (2012). Vitamin D and Google 
Fertility: A Systematic Review. European journal of Endocrinology, Scholar 
166, pp. 765-778. 
78 Lucas, C., Criens-Poublon, L., Cockrell, C. and de Haan, R. (2002). Google 
Wound Healing in Cell Studies and Animal Model Experiments Scholar 
by Low Level Laser Therapy; Were Clinical Studies Justified? A 
Systematic Review. Lasers in Medical Science, 1 7( 2 ), pp. 110-134. 
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TABLE 15.1 Publications included in abstract review (n=100) (cont.) 
Number Reference Source 
79 Mapstone,]., Roberts, I. and Evans, P. (2003). Fluid Resuscita- Google 
tion Strategies: A Systematic Review of Animal Trials.journal of Scholar 
Trauma-Injury Infection & Critical Care, 55(3), pp. 571-589. 
80 Navas-Aden, A., Silbergeld, E., Streeter, R., Clark, J., Burke, T. and Google 
Eliseo Guallar, E. (2006). Arsenic Exposure and Type 2 diabetes: Scholar 
A Systematic Review of the Experimental and Epidemiologic Evi-
dence. Environmental Health Perspectives, 114(5), pp. 641-648. 
81 Pere!, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C., Sandercock, Google 
P., Macleod, M., Mignini, L.,Jayaram, P. and Khan, K. (2007). Scholar 
Comparison of Treatment Effects Between Animal Experiments 
and Clinical Trials: Systematic Review. British Medicaljoumal, 
334(7586), p. 197. 
82 Perlroth,J., Kuo, M., Tan,J., Bayer, A. and Miller, L. (2008). Adjunc- Google 
tive Use of Rifampin for the Treatment of Staphylococcus Aureus Scholar 
Infections: A Systematic Review of the Literature. Archives of 
Internal Medicine, 168(8), pp. 805-819. 
83 Pilchera,J., Weatherall, M., Shirtcliffe, P., Bellomod, R., Young, P. Google 
and Beasley, R.(2012). The Effect of Hyperoxia Following Cardiac Scholar 
Arrest-A Systematic Review and Meta-analysis of Animal Trials. 
Resuscitation, 83(4), pp. 417-422. 
84 Rahimi, R., Mozaffari, S. and Abdollahi, M. (2009). On the Use Google 
of Herbal Medicines in Management of Inflammatory Bowel 
Diseases: A Systematic Review of Animal and Human Studies. 
Digestive Diseases and Sciences, 54(3), pp. 471-480. 
Scholar 
85 Ramberg,]., Nelson, E. and Sinnott, R. (2010). Immunomodulato- Google 
ry Dietary Polysaccharides: A Systematic Review of the Literature. Scholar 
86 
Nutritionjournal, 9, p. 54. 
Ren, Y., Maltba, J. and Kuijpers-Jagtman, A. ( 2003 ). Optimum Google 
Force Magnitude for Orthodontic Tooth Movement: A Systematic Scholar 
Literature Review. The Angle Orthodontist, 73(1), pp. 86-92. 
Rice, A, Cimino-Brown, D., Eisenach,J., Kontinen, V., Lacroix­
Fralish, M., Machin, I. ( on behalf of the Preclinical Pain Con­
sortium), Mogil, J. and Stohr, T. ( 2008 ). Animal Models and the 
Prediction of Efficacy in Clinical Trials of Analgesic Drugs: A 
Critical Appraisal and Call for Uniform Reporting Standards. Pain, 
139 (2), pp. 243-247. 
Google 
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Sculean, A., Nikolidakis, D. and Schwarz, F. (2008). Regenera-
tion of Periodontal Tissues: Combinations of Barrier Membranes 
and Grafting Materials-Biological Foundation and Preclinical 
Evidence: A Systematic Review.Journal of Clinical Periodontology, 
35(8), pp. 106-116. 
Sena, E., van der Worp, H., Bath, P., Howells, D. and Macleod, M. 
( 2010 ). Publication Bias in Reports of Animal Stroke Studies 
Leads to Major Overstatement of Efficacy. Public Library of Sci-
ence Biology, 30,8(3), p. e1000344. 
Shalabi, M., Gortemaker, A., Van't Hof, M.,Jansen,J. and Creugers, 
N. (2006). Implant Surface Roughness and Bone Healing: A Sys-
tematic Review.Journal of Dental Research, 85(6), pp. 496-500. 
Subramaniam, K., Subramaniam, B. and Steinbrook, R. (2004). 
Ketamine as Adjuvant Analgesic to Opioids: A Quantitative and 
Qualitative Systematic Review. Anaesthesia & Analgesia, 99( 2 ), 
pp. 482-495. 
Tetzlaff, W., Okon, E., Karimi-Abdolrezaee, S., Hill, C., Sparling,]., 
Plemel, J., Plunet, W., Tsai, E., Baptiste, D., Smithson, L., Kawaja, 
M., Fehlings, M. and Kwon, B. ( 2011 ). A Systematic Review of Cel-
lular Transplantation Therapies for Spinal Cord Injury.Journal of 
Neurotrauma, 28(8), pp. 1611-1682. 
Ulbrich, B. and Stahlmann, R. ( 2004 ). Developmental Toxicity of 
Polychlorinated Biphenyls (PCBs): a Systematic Review of Experi-
mental Data.Archives of Toxicology, 78(5), pp. 252-268. 
van der Spoel, T., Jansen of Lorkeers, S., Agostoni, P., van Belle, 
E., Gyongyosi, M., Sluijter, J., Cramer, M., Doevendans, P. and 
Chamuleau, S. ( 2011 ). Human Relevance of Preclinical Studies 
in Stem Cell Therapy: Systematic Review and Meta-analysis of 
Large Animal Models of Ischaemic Heart Disease. Cardiovascular 
Research, 91(4), pp. 649-658. 
van der Worp, H., Howells, D., Sena, E., Porritt, M., Rewell, S., 
O'Collins, V. and Macleod M.R. ( 2010 ). Can Animal Models of 
Disease Reliably Inform Human Studies? Public Library of Science 
Medicine, 7(3), p. e1000245. 
van der Worp, H., Sena, E., Donnan, G., Howells, D. and Macleod, 
M. Hypothermia in Animal Models of Acute Ischaemic Stroke: A 
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TABLE 15.1 Publications included in abstract review (n=100) (cont.) 
Number Reference Source 
97 Vang, 0., Ahmad, N., Baile, C., Baur,J., Brown, K., Csiszar, A., Das, Google 
98 
99 
D., Delmas, D., Gottfried, C., Lin, H., Ma, Q., Mukhopadhyay, P., Scholar 
Nalini, N., Pezzuto, J., Richard, T., Shukla, Y., Surh, Y., Szekeres, T., 
Szkudelski, T., Walle, T. and Wu,J. (2011 ). What Is New for an Old 
Molecule? Systematic Review and Recommendations on the Use 
of Resveratrol. PLoS One, 6(6), p. e19881. 
Wennerberg, A. and Albrektsson, T. (2009). Effects of Titanium 
Surface Topography on Bone Integration: A Systematic Review. 
Clinical Oral Implants Research, 20(4), pp. 72-84. 
Wenz, H., Bartsch,J., Wolfart, S. and Kern, M. (2008). Osseoin­
tegration and Clinical Success of Zirconia Dental Implants: A 
Systematic Review. Source. lntemational]oumal of Prosthodon-





100 Wever, K., Menting, T., Rovers, M., van der Vliet,J., Rongen, G., 
Masereeuw, R., Ritskes-Hoitinga, M., Hooijmans, C. and Warle, 
M. (2012). Ischemic Preconditioning in the Animal Kidney: A 
Google 
Scholar 
Systematic Review and Meta-analysis. PLoS One, 7(2), p. e32296. 
Relevant abstracts were assessed overall, depending on the following 
information: 
Clear concordance between human and animal studies. 
Limited concordance between human and animal studies. 
Lack of concordance between human and animal studies, due to one of the 
following factors: Unclear reporting, bias, inconsistency, species differences, 
heterogeneity, and lack of clinical translation. 
It should be noted that the term concordance in this context refers to a quali­
tative, rather than quantitative analysis of the literature within the available 
timeframe. It is also important to note that the systematic reviews analyzed 
and the studies included within these publications (based on eligibility criteria 
assigned by the authors) are just a fraction of thousands of papers reviewed 
but rejected, some spanning four or five decades and using hundreds of thou­
sands of animals. 
Of the 100 abstracts reviewed (50 from PubMed; 50 from Google Scholar) 
none stated unequivocal and conclusive concordance between animals and 
humans. A low proportion of abstracts ( 20%) described limited concordance 
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in specific procedures, but this was generally qualified with an advisory to in­
terpret the findings with caution and the need for more clinical studies to pro­
vide better evidence in humans. 
Species used in studies included rats, mice, rabbits, cats, dogs, sheep, pigs, 
and non-human primates, among others. A wide range of disease areas were 
covered, including several types of cancer, heart disease, stroke, neurological 
disorders ( e.g. ,  Alzheimer's and Parkinson's disease), diabetes, bone defects 
and facial disorders, dental research, gene therapy and stem cell research, to 
provide some examples. Several publications were general reviews of how ani­
mal data translates to humans, as well as reviews of animal studies in specific 
disease areas. 
The large majority of reviews ( 75%) found that assessment of human re­
sponse from animal data is significantly limited due to one or more of the 
following factors: species differences, lack of clinical translation, poor quality 
methodology, inconsistency, and publication bias, resulting in overstatement 
of the benefits of animal use in predicting human disease outcomes or safety. 
There was a distinct lack of evidence clinically, despite many therapies in use 
based on animal studies. Numerous reviews highlighted the successes claimed 
over basic research outcomes or new therapies in animal "models", which have, 
however, failed to translate to the clinic to help patients (Hirst et al. , 2016). 
Concerns over paucity of evidence, publication bias and consequently, over­
statement of benefit in translating animal data to humans have led to many 
systematic reviews (Briel et al. , 2013). 
A key finding from this review is that, not only is publication bias very com­
mon in animal research, but many additional results considered unsuccess­
ful remain unpublished. This issue was raised in a number of the systematic 
reviews analyzed, for example in animal models of stroke (Sena et al. , 2010 ). 
Several reviews also raised concerns over animal studies and human trials be­
ing carried out simultaneously (Horn et al. , 2001; Lucas et al. , 2002 ). Moreover, 
this analysis found several studies (5% of the sample reviewed), highlighting 
animal experiments that could have been entirely omitted and carried out di­
rectly and far more effectively and ethically in clinical or observational studies 
in humans; for example, studies on dietary intake and cardiovascular health 
(Reis et al. , 2016; Raynor et al. , 2015), or trials of substances already in human 
use (Rogers et al. , 2016). In many cases, human trials were carried out in paral­
lel with animal experiments, representing examples of animal use that can be 
abandoned. This is discussed later in this chapter in more detail. 
The findings from the majority of publications reviewed are consistent 
with other evidence on the problems of translating animal data to humans; 
for example, the Review of Research Using Non-human Primates (jointly 
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commissioned in 2006 by a number of major UK research councils and chaired 
by Sir David Weatherall). A subsequent review in 2011 addressed one of the re­
commendations in the Weatherall report, to review ten years of brain research 
in monkeys retrospectively. Not only did the review reveal some disturbing in­
sights into the routine suffering of non-human primates used in neurology, but 
it reported the equally concerning finding that "In most cases, however, little 
direct evidence was available of actual medical benefit in the form of changes 
in clinical practice or new treatments" (Biotechnology and Biological Sciences 
Research Council, 2011, p. 13) .  These findings were emphasized more recently 
in the Review of the  Assessment of Cumulative Severity and Lifetime Experience 
in Non-human Primates Used in Neuroscience Research, published in November 
2013 by the (then) Animal Procedures Committee (AP C ,  now Animals in Sci­
ence Committee) (AP C ,  2013) .  
Further evidence of increasing concern over the validity of animal research 
was highlighted in a British Medical Journal review entitled, How Predictive 
and Productive is Animal Research?, which concluded that "Funds might be 
better directed towards clinical rather than basic research, where there is a 
clearer return on investment in terms of effects on patient care" ( Godlee, 2014, 
p. 1). This article adds to a wealth of evidence on the poor performance of 
animals in predicting human responses, with an accuracy of approximately 
20%-60%, depending on reviews cited (Perel et al. , 2007; van Meer et al. , 2012 ) .  
Additionally, in a series of studies between 2013-2015, a collaboration between 
the Fund for the Replacement of Animals in Medical Experiments and Cruelty 
Free International involved the analysis of an unprecedented level of indepen­
dent data from both preclinical toxicity studies and human clinical trials. The 
studies revealed the inadequacies of animal toxicity studies in a number of 
species (i.e. , dog, rabbit, mouse, rat, and non-human primate) in predicting 
human adverse events; and the urgency for more human-relevant methods to 
be developed (Bailey et al. , 2013, 2014, 2015) .  
To some extent the pharmaceutical industry recognizes that the models it 
has been using are inadequate. There is encouraging research into alternative 
approaches and further consideration of the problem in some areas (Bloom­
berg, 2013).  In 2014, the National Institutes of Health (NI H ), Tissue Chip Pro­
gram, began the investigation of more than 100 drugs that showed success in 
rodents but went on to fail in human trials ( N I H ,  2016) .  
With regard to the purpose of experiments covered by the reviews exam­
ined, the majority of publications focused on basic research in animals ( 66% ).  
This was expected, given that this is the largest area of animal use. The re­
maining 34% were concerned with reviewing safety or efficacy of substances, 
including new and existing drugs, herbal therapies, or food related additives or 
substances ( e.g. , low calorie sweeteners) (Rogers et al. , 2016 ) .  
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2 Review of Toxicity Studies in Animals, Focusing on Three Well-
known Examples 
A follow-up literature review was performed to further address publications of 
toxicity tests in animals. This specific sample of the most recent literature was 
chosen to provide meaningful case studies on three well-known and widely­
used drugs worldwide: paracetamol (acetaminophen), aspirin and penicillin. 
Information on these studies is presented in Table 15.2, and each drug is briefly 
discussed below. 
2.1 Paracetamol 
Paracetamol was first marketed in the 195o's (Sneader, 2005) and is well known 
as one of the world's most common household drugs, traded under many dif­
ferent brand names, including Tylenol and Panadol. Despite being marketed 
for over five decades and the vast availability of data on global human use, 
paracetamol continues to be routinely tested on animals, both for "blue sky" 
research and attempts to market it for new purposes. Using a similar method­
ology to the previous review, the general key search terms of "paracetamol tox­
icity animals" resulted in 2,431 listings in PubMed. (Note: Using similar terms 
"acetaminophen toxicity animals" provided 2,358 listings and a brief review 
established, as expected, that many of these were the same results). 
Review of the first five listings under the above search term, published 
between 2014-2016, provided extensive evidence of ongoing experimental 
research into paracetamol in animals. For example, hepatotoxicity has been well 
known for decades as a risk of paracetamol overdose in humans, yet, induc­
ing such effects in mice is still carried out routinely, worldwide (Pingili et al. ,  
2015). Further recent studies show that macaques are considered a poor model 
due to their resistance to paracetamol poisoning when compared to humans 
(Yu et al. ,  2015). Experimental dosing and killing of newborn mice continues 
(Viberg et al. ,  2014), despite paracetamol's widespread global use in children 
and pregnant mothers, as shown by far more directly relevant clinical or obser­
vational studies to check for effects on offspring (Liew et al. ,  2014). Other ex­
perimental studies included, force feeding of GM mice with a drug to inhibit an 
enzyme that activates the toxic response to paracetamol in order to investigate 
resistance (Pu et al. ,  2016), and numerous similar, experimental testing in mice 
(Hohmann et al. ,  2013), despite much earlier, advanced human-based studies 
to investigate resistance to paracetamol toxicity (McCloskey et al. ,  1999 ). 
Another publication investigated a widely-used industrial chemical that 
humans are routinely exposed to in the environment via air, diet, and wa­
ter: aniline. The aim of the study was to investigate aniline's conversion to 
paracetamol, and its effects on male fertility. Yet, instead of employing the 
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TABLE 15 . 2  Review of publications relating to paracetamol, aspirin, and penicillin 
Number 







Adi, 0., Demir-Ozkay, U., Ilgin, S., Aydin, T., Akbulut, E. and 
Sener, E. (2016). Evidence for Neurotoxicity Associated with 
Amoxicillin in Juvenile Rats. Human & Experimental Toxicology, 
35(8), pp. 866-876. 
Cappon, G., Gupta, U., Cook,J., Tassinari, M. and Hurtt, M. 
( 2003 ). Comparison of the Developmental Toxicity of Aspirin 
in Rabbits When Administered Throughout Organogenesis 
or During Sensitive Windows of Development. Birth Defects 
Research Part B: Developmental and Reproductive Toxicology, 
68( 1 ), pp. 38-46. 
Chao, Y., Lee, C., Liu, K., Wang, Y., Wang, C. And Liu, S.(2015). 
Sustained Release of Bactericidal Concentrations of Penicillin 
in the Pleural Space via an Antibiotic-eluting Pigtail Catheter 
Coated with Electrospun Nanofibers: Results from In Vivo and 
In Vitro Studies. International journal of Nano medicine, 4( 10 ), 
pp. 3329-3336. 
Feinstein, A., Heinemann, L., Curhan, G., Delzell, E., 
DeSchepper, P., Fox,J., Graf, H., Luft, F., Michielsen, P., Mihatsch, 
M., Suissa, S., van der Woude, F. and Willichet, S. ( 2000 ). 
Relationship Between Nonphenacetin Combined Analgesics 
and Nephropathy: A Review. Kidney International 58(6), 
pp. 2259-2264. 
Holm,J., Chalmey, C., Modick, H.,Jensen, L., Dierkes, G., Weiss, 
T.,Jensen, B., N0rregard, M., Borkowski, K., Styrishave, B., Koch, 
H., Severine, M.,Jegou, B., Kristiansen, K. and Kristensen, D. 
(2015). Aniline Is Rapidly Converted into paracetamol impair-
ing Male Reproductive Development. Toxicological Sciences, 
148( 1 ), pp. 288-298. 
Hueper, K., Elalfy, M., Laenger, F., Halter, R., Rodt, T., Galanski, 
M. and Borlak,J. (2012). PET/CT Imaging of c-Myc Transgenic 
Mice Identifies the Genotoxic N-nitroso-diethylamine as 









107 Huggett, A, Schilter, B., Roberfroid, M., Antignac, E. and PubMed 
KoemanJ.H. (1996). Comparative Methods of Toxicity Testing: 
Consensus Document Following an International Life Sciences 
Institute-I LSI  Europe Workshop Held in May 1995. Food and 
Chemical Toxicology, 34(2), pp. 183-192. 
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108 
109 
Jefferies, S., Saxena, M. and Young, P. (2012). Paracetamol In 
Critical Illness: A Review. Critical Care and Resuscitation, 14( 1 ), 
pp. 74-80. 
Jegatheeswaran, S. and Siriwardena, A. (2010 ). Experimental 
and Clinical Evidence for Modification of Hepatic Ischaemia­
reperfusion Injury by N-acetylcysteine During Major Liver 
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TABLE 15 . 2  Review of publications relating to paracetamol, aspirin, and penicillin (cont.) 
Number Reference Source 
117 Yu, H., Barrass, N., Gales, S., Lenz, E., Parry, T., Powell, H., 
Thurman, D., Hutchison, M., Wilson, I., Bi, L., Qiao, J., Qin, 
Q. and Ren,J. (2015). Metabolism by Conjugation Appears 
to Confer Resistance to Paracetamol (Acetaminophen) 
Hepatotoxicity in the Cynomolgus Monkey. Xenobiotica, 45(3 ), 
pp. 270-277. 
PubMed 
directly relevant approach of investigating the vast amount of already avail­
able clinical and observational exposure data, groups of mice were injected, 
before being killed and dissected along with their offspring, for examination 
(Holm et al. , 2015) . 
As well as review of specific experiments on paracetamol toxicity in ani­
mals, further publications published between 1996 and 2012 on systematic 
reviews of paracetamol toxicity were analyzed ( see Table 15.2 ) . Included were 
reviews of translating animal models of paracetamol toxicity to humans, 
stating that "Considerable effort has been made to predict and model drug­
induced liver injury in humans using laboratory animals with only little suc­
cess and even some controversy" (McGill and Jaeschke, 2014, p. 10 ). A further 
review of paracetamol, and similar drugs in its class, concluded that there was 
insufficient evidence based on animal ( and human) tests to assess toxic effects 
on the human kidney (Feinstein et al. , 2000 ). An analysis of clinical treatment 
for paracetamol-induced injury during liver surgery documented 19 different 
studies carried out on mice, rats, dogs, and pigs with varying results, conclud­
ing that evidence was insufficient to suggest the therapy was clinically relevant 
(Jegatheeswaran and Siriwardena, 2010 ). 
The remaining reviews focused on how paracetamol, over two decades ago 
( as one of a group of "well-studied" hepatoxicants ), highlighted the need to 
evaluate links between in vitro and in vivo testing strategies (Huggett et al. , 
1996 ); and more recently, despite the extensive toxicity testing of paracetamol, 
evidence supporting its use in specific groups of patients ( e.g. , the critically 
ill) was considered lacking (Jefferies et al. , 2012) , highlighting the value of data 
that can only be gathered in clinical research. When taken in normal regu­
lar doses, paracetamol is largely considered safe in humans for a number of 
pain associated conditions. Yet, it causes a wide range of toxicities in many 
species, for example, cancer in mice and rats (Hueper et al. , 2012 ). In fact, given 
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requirements today for extensive regulatory toxicity testing in animals, it is 
highly likely that paracetamol would be denied approval based on its poor 
safety profile in animals. 
2.2 Acetylsalicylic Acid (Aspirin) 
Acetylsalicylic acid, commonly known as Aspirin, has been in human use for 
more than a century. It is still considered successful; and given its relatively 
cheap production costs and widespread use for a number of indications, it is 
still considered a "blockbuster" drug in terms of revenue (Hartung, 2009 ). Yet, 
the human relevant dose of aspirin is lethal to rats and causes toxic effects in 
many animal species, including embryonic deformities in dogs, cats, mice, rats, 
monkeys, and rabbits (Barrow, 2002 ). Like paracetamol, given the poor safety 
record of aspirin in animals, it would very likely be denied approval for human 
use if newly marketed, according to today's regulatory testing requirements 
(Hartung, 2009 ). Aspirin continues to be routinely tested on animals, despite 
availability of vast libraries of both historical and new human data. 
With the same methodology and sampling as the previous reviews, the 
search terms, "aspirin toxicity animals" were used. PubMed revealed experi­
ments carried out between 2012-2016, including 15-day oral toxicity studies of 
derivatives of aspirin in Wistar rats and subchronic toxicity studies in mice 
( see Table 15.2 ). Searching for publications under the terms "acetylsalicylic acid 
toxicity in animals" resulted in specific studies published between 2000-2013. 
These included administration of large doses to pregnant rabbits, concluding 
that aspirin is not teratogenic to them, and highlighting inconsistencies with 
previous rabbit experiments and species differences with rats, having been "ex­
tensively studied" and exhibiting birth defects (Cappon et al. , 2003). 
2.3 Penicillin 
Alexander Fleming's pioneering work on penicillin is well known. Following 
this, Florey and Chain won a Nobel Prize in the 194o's for successful results in 
mice with penicillin; yet, they considered themselves fortunate to have chosen 
to test mice instead of guinea pigs, who showed lethal side effects to the drug, 
as Florey later remarked: "Mice were used in the initial toxicity tests because 
of their small size, but what a lucky chance it was, for in this respect man is 
like the mouse and not the guinea pig. If we had used guinea pigs extensively 
we should have said that penicillin was toxic and we probably should not have 
proceeded to try and overcome the difficulties of producing the substance for 
trial in man" (Florey, 1953, p. 12 ). 
In fact, penicillin is safe, to some extent, in mice and rats but has severe, 
often lethal, effects in hamsters and guinea pigs due to their very sensitive 
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intestinal microbiota, making them particularly susceptible when compared 
to other species. Animal users are quick to respond to this issue, stating that 
multiple species are used to assess the most appropriate "model" for humans 
and account for differences (heterogeneity) in animals. Again, no dispute is 
made on this; indeed, this has been the tenet in toxicology for decades, testing 
in different species and varying doses, modifying their condition either geneti­
cally, chemically or physically in an attempt to elicit the reaction needed. Yet, 
the high attrition rate of new pharmaceuticals and lack of progress in key areas 
of disease research should suggest that something is wrong. The use of animals 
is the only area of scientific research where the same dated techniques are 
still being used 60-70 years later, despite their limitations being well known. 
No other area of science continues to use such a dogmatic approach. As evi­
dence of this, a general literature review of the search terms "penicillin tox­
icity animals" results in numerous publications over decades, several of the 
most recent listings (2011-2016, see Table 15. 2) involving rats, rabbits, and other 
animals; even using penicillin in repeated experiments to induce effects, in­
cluding anxiety and depression ( to try to mimic effects in rats already seen in 
patients), weight loss, organ failure, and deliberate epilepsy to test the effects 
of other drugs that, like penicillin, are already in extensive global use, with a 
wealth of clinical toxicity data available. 
3 Part 2: Drivers for Change-Development of Animal-free Testing 
Methods 
It should be noted that use of the term alternatives in this chapter refers only 
to methods that replace the use of animals and their tissues. It is necessary to 
make this distinction, given the widely-used terminology of the 3Rs ( replace­
ment, reduction and refinement), first proposed in The Principles of Humane 
Experim ental Technique (Russell and Burch, 1959 ). The ultimate goal of Russell 
and Burch in establishing the 3Rs was replacement. While measures to refine 
methods or reduce animal numbers are, of course, to be encouraged, much at­
tention is devoted to these 2Rs and, to some extent, it has diverted focus from 
replacement. 
Given six decades of the 3R principles, dedicated attention to replacement 
is long overdue. This is also reflected in European Directive 2010/63/EU on 
animals used for scientific purposes (European Parliament, 2010, p. 2 ), which 
states that it "represents an important step towards achieving the final goal of 
full replacement of procedures on live animals for scientific and educational 
purposes as soon as it is scientifically possible to do so. To that end, it seeks to 
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facilitate and promote the advancement of alternative approaches." Although 
the Directive was implemented in January 2013, there has been relatively little 
decrease and, in many cases, an increase in animal use across individual Mem­
ber States. Therefore, there is still great scope for improvement, particularly 
with regard to funding the development, acceptance, and adoption of animal­
free, human-based methods. 
Furthermore, the broad interpretation of the term alternatives under the 
auspices of the 3Rs is used to describe the use of some animals as "alternatives" 
to others, for example the use of zebrafish over rodents (Charles River, 2016); 
transgenic mice to "replace" non-human primates (Home Office, 2014); and 
even the use of minipigs, instead of dogs, as an "alternative" that may be more 
acceptable to the public, because they are considered "food animals" (Forster 
et al. , 2010 ). Aside from the poor ethical argument, replacing one animal with 
another still fails to address the wrong model problem. 
Use of public opinion and political lobbying to drive legislative change 
remains vital to fueling research and developments in animal-free science. 
The clearest example in recent years is the phased-in bans on animal-tested 
cosmetics across the E U  between 2009-2013 (European Commission, 2013). 
A testing ban on cosmetic ingredients was enforced from March 11, 2009, along 
with a partial marketing ban for 10 animal-test requirements. This was even­
tually followed by a further marketing ban from March 11, 2013 for endpoints 
considered more complex (i.e. , repeat dose toxicity, skin sensitization, repro­
ductive toxicity, carcinogenicity, and toxicokinetics). However, for safety data 
requirements of cosmetic substances, some of these endpoints are rarely or not 
required (Nohynek et al. , 2010 ). Despite delays in implementing the bans and 
legal challenges attempting to abolish them altogether, they had a monumen­
tal effect on the industry, with the development of numerous in vitro methods 
to be ready in time. Despite loopholes with conflicting chemicals safety-testing 
legislation, such as Registration, Evaluation, Authorisation and Restriction of 
CHemicals (REACH )  (European Chemicals Agency, 2007), the bans have been 
responsible for one of the most significant advances towards replacing animal 
tests in decades. 
The campaign to end cosmetics tests on animals began in the 1970s, and it 
took until 1993 to see legislation amendments to mark the implementation of 
official E U  bans. After a further two decades of delays, the bans were finally en­
forced, with significant resistance amid claims that innovation would be stifled 
and that the development of alternatives would not be possible. Instead, the 
opposite was achieved. The development of in vitro methods was stimulated to 
address a number of toxicological endpoints ( the result of a study to determine 
how toxic a substance is). The endpoints included skin irritation, eye irritation, 
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skin corrosion, phototoxicity, skin absorption/penetration, acute toxicity, and 
genotoxicity/mutagenicity. In preparation for the forthcoming bans, around 
30 new in vitro assays were validated by 2007 (Hartung, 2008), with more 
developed since and projections that the in vitro toxicity testing market will 
be worth us$17, 227 million by 2018 (PR Newswire, 2014). The bans have also 
affected positive change outside EU borders, with similar bans now in place in 
India, Israel, Norway, and New Zealand, as well as partial or full enforcements 
in many other countries. 
4 Methods Now Available, Previously Considered Only Possible in 
Animals-Some Examples 
Replacement can be ( and is being) achieved by a number of approaches, in­
cluding in vitro and in silica models. Some examples are discussed below. 
In its 2014 Delivery Plan, Working to reduce the use of animals in scientific 
research, the UK Home Office devoted much of the text to supporting the con­
tinuance of animal research. However, the plan also showcases human in vitro 
methods, for example, using induced pluripotent stem cells (Yusa et al. , 2011), 
which it describes as "work that in the past could only have been modelled in 
animal systems" (Home Office, 2014, p. 16). 
Scientists at the University of Newcastle have developed human skin-based 
assays, using cells isolated from the blood sample of healthy volunteers to as­
sess new drugs, cosmetics and household products. The technology, now mar­
keted as Skimune by Alcyomics Ltd, could have predicted the adverse effects 
seen in the volunteers of the TGN1412 monoclonal antibody clinical trial in 
2006 (Alcyomics, 2017). 
Other high performance initiatives include physiologically-based pharma­
cokinetic modelling (PBPK), which quantitatively predicts the characteristics 
of substances in the body ( e.g., blood flow or effects on organs). The introduc­
tion of in vitro PBPK models over the past two decades is credited with re­
ducing drug failure rates from over 40% to under 10% (McKim, 2010 ). Another 
major area of replacement research uses devices, known as Multi Organ Chips 
(MO C ), to mimic the human body's response to chemicals and disease pro­
cesses, with the ultimate goal being a human on a chip. Over the past few years, 
advances in MOC technology have been exponential. For example, the organ 
on a chip devices developed at Harvard's Wyss Institute can mimic events in 
tissue function and disease, such as air flow, bacterial infection, immune sys­
tem response, blood clotting, fluid leakage and, most recently, electrical activ­
ity across cells, to predict safety and disease mechanisms in patients (Wyss 
Institute, 2017 ). For further discussion see Wilkinson, 2019, Chapter 26. 
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At the United States N I H  Chemical Genomics Centre, a major testing pro­
gram has been underway since 2004, involving a robotic-arm system that tests 
thousands of chemicals, using patient donated cells. The high throughput 
system performs approximately 3 million tests per week in relation to a differ­
ent disease. The success of the system ( also funded under the Toxico logy in the 
21st Century, ToX21, initiative) in screening and identifying suitable candidate 
drugs has dramatically saved time, cost, and resources, resulting in human 
clinical trials starting within a year. 
A further groundbreaking concept is the Adverse Outcome Pathway (AOP ), 
a key component of the paradigm shift towards human-relevant methods and 
establishing a robust system for predicting human safety. An AOP is a sequence 
of events that starts by a chemical effect at the molecular level ( termed a Mo­
lecular Initiating Event) and progresses through changes ( termed Key Events) 
in cells, tissues, and organs to produce an adverse effect in the body. AOPs  act 
as a bridge between emerging methods of safety testing and, ultimately, what 
happens in the body in response to a particular substance (xenobiotic). With 
increasing knowledge, AOPs  can be linked to form networks, revealing adverse 
outcomes that share pathways and vice versa. One example is the establish­
ment of in vitro test methods that map the three key stages of the AOP for skin 
sensitization, now accepted at Organisation for Economic Co-Operation and 
Development (oECD) level (2015). Before the EU cosmetic testing bans were 
implemented, there was a high level of skepticism over the prospect of testing 
substances for skin sensitization ( and other complex endpoints) without the 
use of animals; and while further work remains to be done, major progress has 
been made. The AOP program was established in 2012 and, including skin sen­
sitization, there are now six AOPs  approved at the OECD level; five relating to 
human health effects and one to address potential ecotoxicological effects to 
wildlife (fish, birds, and amphibians). A further 227 AOPS  are in development 
(OECD, 2017). 
In addition to new in vitro and in silico models to address safety testing, other 
areas of animal use previously considered essential, such as education, have 
seen coordinated replacement initiatives. Although animals are still used ex­
tensively in this area, great successes have been achieved to date. For example, 
campaigns by all involved in the International Network for Humane Education 
(InterNICHE) project to provide training and disseminate information on hu­
mane methods in medicine, biology, and veterinary research ( e.g. , mannequins 
and simulation techniques) continue to affect great change in universities and 
schools worldwide (InterNICHE, 2017). Other progress is being made in edu­
cation as well. In 20161 Washington University announced it would end its 25-
year use of cats for intubation training ( the last university in the United States 
still using cats in this way). Instead, it will now use mannequins and advanced 
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simulators, following significant investment in its simulation center, which 
made the decision possible, following sustained public awareness campaigns 
(Physicians Committee for Responsible Medicine, 2016). Also in 2016, John­
son and Johnson subsidiary, Ethicon, finally agreed to remove live pigs from its 
medical-device training program, stating that it "discontinued live animal use in 
salestrainingacrossourNorthAmericaregion"(PeoplefortheEthicalTreatmentof 
Animals, 2016 ). For further discussion see Pawlowski, et al. , 2019, Chapter 22. 
In addition to the vast range of human-based technologies now available, 
another sensible approach is to improve the use of data from clinical, epide­
miological, and biomonitoring studies. All of these have been considerably 
underused to date and could not only improve patient-safety and disease 
research but avoid the unnecessary use of animals. 
5 Abandonment of Redundant and Duplicative Animal Tests 
The ethical arguments concerning use of animals and problems with scien­
tific validity are compounded further by the issue of duplicative experiments, 
which is a widespread problem. Many of the same tests are carried out over 
and over again, often amid claims of needing to maintain confidentiality and 
preserving intellectual property, despite mandates to share data. One example, 
a robust analysis of safety data submitted under the REACH program, recently 
revealed that, incredibly, the Draize eye irritation test had been carried out on 
rabbits for two chemicals, 90 times per substance. (Luechtefeld et al. , 2016). 
Not all tests need replacing. Many can end now as they are out of date or 
have been found to be redundant. A recent case is the deletion of the single­
dose toxicity test from the European Medicines Agency guidelines, after it was 
recognized that information from the test could be obtained elsewhere, and 
that the test was of limited value (European Medicines Agency, 2010 ). Further­
more, there are many examples of animal tests that require a root and branch 
analysis and retrospective assessment to not only assess whether scientif­
ic objectives were met but also whether such procedures should have been 
approved at all. A case study to demonstrate this further is the European Coali­
tion to End Animal Experiments (ECEAE ). In 2014, ECEAE estimated that its 
strategy of toxicological review and comment on animal testing proposals for 
chemicals registered under the REAC H legislation saved at least 18,000 animals, 
through rejected and withdrawn proposals. This was achieved on the basis of 
existing data or evidence that the tests proposed were unnecessary or unjusti­
fied (ECEAE, 2014). Another recent example is the welcome decision that the 
year-long chronic-toxicity test for pesticides is no longer required in dogs, on 
the basis that it is not scientifically justified (Kobel et al. , 2010 ). The test has 
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been dropped in the E U, the United States, and Canada. Although there are 
still requirements for the one-year test to be carried out in other countries, 
the restrictions mark a change in attitudes and a meaningful review of testing 
requirements. The campaign continues to see the test abolished worldwide as 
soon as possible. 
6 Conclusion 
The aim of this chapter was to provide a qualitative overview of evidence 
from systematic reviews and some individual studies of not only the flawed 
approach to the continued use of animals in trying to predict mechanisms 
of human disease; but also the success of existing and emerging animal-free 
methods, the opportunities for intelligent use of human-based data, and the 
distinction between animal tests that require replacement and those that can 
simply end. 
Advances in science, providing better technologies on an ongoing basis, 
should pave the way for acceptance of non-animal methods. In some areas, 
such as cosmetics testing, there is unprecedented change and global recog­
nition that animal use must end. Yet, in other areas of animal research, de­
spite a wealth of better science, the realities of some conventional attitudes, 
resistance to change, and an industry reliant on the continuation of animal 
experimentation ( e.g., major establishments funded by long-term programs 
of animal research, financial partnerships, GM animal breeding, commercial 
breeders, suppliers, and transporters of animals) mean that political lobbying, 
campaigning, and raising public awareness must continue to play a major role. 
Fortunately, there are a number of animal protection, political, and scientific 
stakeholders who continue to work in the field, actively pushing for change, to 
increase recognition that animal research must end and to achieve the para­
digm shift that is urgently needed for humans and animals. 
Dedication 
This chapter is dedicated to Andrew Tyler. 
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